- Trials with a EudraCT protocol (133)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
133 result(s) found for: Norepinephrine.
Displaying page 2 of 7.
EudraCT Number: 2014-002685-70 | Sponsor Protocol Number: 300A | Start Date*: 2015-08-03 |
Sponsor Name:Lund University | ||
Full Title: The Effect of Sitagliptin on Glucagon Dynamics and Incretin Hormones During Mild Hypoglycemia in Elderly Patients with Metformin-Treated Type 2 Diabetes | ||
Medical condition: Type 2 Diabetes Mellitus | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001827-41 | Sponsor Protocol Number: PI2020_843_0094 | Start Date*: 2021-06-11 |
Sponsor Name:CHU Amiens-Picardie | ||
Full Title: Evaluation of the early use of norepinephrine in major abdominal surgery on postoperative organ dysfunction | ||
Medical condition: major abdominal surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000254-39 | Sponsor Protocol Number: 20111001 | Start Date*: 2011-10-11 |
Sponsor Name:Anestesi och Operationskliniken | ||
Full Title: Perioperative Goal Directed Fluid Therapy during Esophageal Resection. A prospective randomized controlled open multi-centre trial to study the effect on postoperative complications | ||
Medical condition: Anesthesia for esophageal resection because of malignancy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002653-31 | Sponsor Protocol Number: VF20040171 | Start Date*: 2004-11-25 |
Sponsor Name:Odense University hospital | ||
Full Title: CAPHI. Profylactic effect of Ca2+ sensitizer versus phosphodiesterase inhibitor infusion at CAGB patients with preoperative low ejection fraction. A prospective randomised clinical trial. | ||
Medical condition: Perioperative use of Milrinon to CAGB patients has shown to reduce postoperative complications. Levosimendan improves cardiac performance without interfering with the calcium turnover and there by ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001067-23 | Sponsor Protocol Number: PasHypo | Start Date*: 2018-05-07 | |||||||||||
Sponsor Name:Zealand University Hospital | |||||||||||||
Full Title: Pasireotide in the treatment of hypoglycemia following gastric bypass surgery | |||||||||||||
Medical condition: Postprandial reactive hypoglycemia in patients with prior Roux-en-Y gastric bypass surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-006913-26 | Sponsor Protocol Number: FLACC2008 | Start Date*: 2009-01-20 | ||||||||||||||||
Sponsor Name:Departement of orthopaedic surgery, Århus Sygehus | ||||||||||||||||||
Full Title: Postoperative smerter efter bækkenosteotomi med lokal infiltrationsanalgesi hos børn med cerebral parese. Et prospektivt, randomiseret og dobbeltblindet studie. | ||||||||||||||||||
Medical condition: cerebral parese | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005157-24 | Sponsor Protocol Number: 75688 | Start Date*: 2021-09-21 | |||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||
Full Title: [18F]mFBG PET-CT imaging of pheochromocytoma | |||||||||||||
Medical condition: Pheochromocytoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005253-30 | Sponsor Protocol Number: 9876543123xz | Start Date*: 2006-12-22 |
Sponsor Name:Queen Mary's School of Medicine & Dentistry, University of London | ||
Full Title: Study of the effects of different targets for perfusion pressure on tissue perfusion and oxygenation in patients suffering from septic shock | ||
Medical condition: Septic shock | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-001908-23 | Sponsor Protocol Number: 13-5-23-9-3-8-15 | Start Date*: 2008-06-20 |
Sponsor Name:Rigshospitalet, Department of Clinical Pharmacology | ||
Full Title: A randomised, double blinded, crossover study of the influence of Metoprolol on exercise induced elevation of catecholamines in healthy subjects. | ||
Medical condition: The medical condition to be investigated is heart failure, but this specific study is made on healthy volunteers to investigate the influence of metoprolol on exercise induced elevation of catechol... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001915-22 | Sponsor Protocol Number: CKN-DASI-RYGB | Start Date*: 2019-09-05 | |||||||||||
Sponsor Name:Center for Clinical Metabolic Research at Herlev-Gentofte Hospital | |||||||||||||
Full Title: Dasiglucagon in the treatment of postprandial hypoglycaemia after Roux-en-Y gastric bypass | |||||||||||||
Medical condition: Postprandial hyperinsulinemic hypoglycaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002992-33 | Sponsor Protocol Number: 54135419TRD3013 | Start Date*: 2020-08-04 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Randomized, Open-label, Rater-Blinded, Active-Controlled, International, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Flexibly Dosed Esketamine Nasal Spray Compared Wit... | |||||||||||||
Medical condition: Treatment-Resistant Major Depressive Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) CZ (Completed) PL (Completed) DE (Completed) HU (Completed) FR (Completed) BE (Completed) PT (Completed) BG (Completed) DK (Completed) AT (Completed) NO (Completed) FI (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000412-27 | Sponsor Protocol Number: ARG-CS3-001 | Start Date*: 2005-08-22 |
Sponsor Name:Arginox Pharmaceuticals, Inc. | ||
Full Title: A Phase III International Multi-center, Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Nitric Oxide Synthase Inhibition with Tilarginine Acetat... | ||
Medical condition: It is the intent of the proposed study to further evaluate the safety and efficacy of Tilarginine Acetate Injection as a novel, mortality reducing therapeutic drug for patients with cardiogenic sho... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) DE (Prematurely Ended) HU (Prematurely Ended) AT (Completed) CZ (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004565-24 | Sponsor Protocol Number: CNS7056-011 | Start Date*: 2015-06-22 | |||||||||||
Sponsor Name:PAION UK Limited | |||||||||||||
Full Title: A Randomized, Single-blind, Propofol-controlled Phase III Study Evaluating the Efficacy and Safety of Remimazolam in General Anesthesia in Adult Patients Undergoing Cardiac Surgery, Including Follo... | |||||||||||||
Medical condition: Anesthesia in adult patients undergoing cardiac surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Prematurely Ended) NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004625-24 | Sponsor Protocol Number: AP-recAP-AKI-03-01 | Start Date*: 2020-09-04 | |||||||||||||||||||||
Sponsor Name:AM-Pharma B.V. | |||||||||||||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel Group, Multi-Center Phase 3 Pivotal Trial to Investigate the Efficacy and Safety of Recombinant Human Alkaline Phosphatase for Treat... | |||||||||||||||||||||||
Medical condition: Sepsis-associated acute kidney injury | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Prematurely Ended) NL (Completed) DK (Prematurely Ended) FI (Completed) DE (Prematurely Ended) GB (GB - no longer in EU/EEA) BE (Completed) IE (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-021215-16 | Sponsor Protocol Number: H9P-MC-LNBQ | Start Date*: 2011-02-17 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A Randomized, Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 mg to 18 mg Once Daily and LY2216684 Fixed-Dose 6 mg Once Daily as Adjunctive Treatment for Patients with Major De... | |||||||||||||
Medical condition: Major depressive disorder (MDD) | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) FI (Completed) SK (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000174-29 | Sponsor Protocol Number: CNS7056-022 | Start Date*: 2018-07-25 | ||||||||||||||||
Sponsor Name:PAION UK Limited | ||||||||||||||||||
Full Title: Phase III confirmatory efficacy and safety trial of remimazolam (CNS7056) compared with propofol for intravenous anaesthesia during elective surgery | ||||||||||||||||||
Medical condition: Induction and maintenance of general anaesthesia (GA) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) BE (Completed) GB (Prematurely Ended) NL (Prematurely Ended) FR (Completed) IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-002767-41 | Sponsor Protocol Number: mobil-c1 | Start Date*: 2008-02-29 |
Sponsor Name:Sonderforschungsbereich 656 (SFB 656) | ||
Full Title: Kardiale Innervation bei genetischen Arrhythmiemodellen in Menschund Maus | ||
Medical condition: The longQT-syndrome is a genetically detemined malfunction of ion channels. The identified genes in longQT-patients encode cardiac ion channels or accessory proteins affecting the function of diffe... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-000073-37 | Sponsor Protocol Number: Version 1 FFF | Start Date*: 2008-09-24 |
Sponsor Name:Oxford Radcliffe Hospitals NHS Trust | ||
Full Title: Assessment of the effects of pressors on graft blood flow after free tissue transfer surgery | ||
Medical condition: Patients in need of free flap facial reconstructive surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-000170-30 | Sponsor Protocol Number: MULTIPAIN-2-3-2013 | Start Date*: 2013-04-19 | |||||||||||
Sponsor Name:Mech-Sense, Aalborg University Hospital | |||||||||||||
Full Title: Effects of oxycodon and venlafaxine on human pain processing. A randomized, double-blinded, placebo-controlled, cross-over study | |||||||||||||
Medical condition: Healthy volunteers - pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000237-48 | Sponsor Protocol Number: MiraBAT01 | Start Date*: 2016-04-20 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: The effect of Mirabegron on brown adipose tissue in healthy young white Caucasian and South Asian men | ||
Medical condition: Obesity and dyslipidemia | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
